Intermountain Health, the largest nonprofit healthcare provider in the Intermountain West region, struck a multi-year collaboration with a young generative AI startup this month. The health system is ...

Investment led by UPMC Enterprises, with participation from MemorialCare Innovation Fund, Rex Health Ventures, Tampa General Hospital Ventures, Memorial Hermann Health System, Frist Cressey Ventures, ...

Intermountain Health is deploying Layer Health’s artificial intelligence for clinical data abstraction to improve its quality reporting and clinical registry submissions in stroke, surgery and ...

SAN FRANCISCO, Feb. 11, 2025 /PRNewswire/ -- The vast majority of clinical data abstractors believe AI would save them time, effort and cost, but concerns about data quality without human oversight ...

Salt Lake City-based Intermountain Health is partnering with health AI company Layer Health to streamline how it manages clinical data. The multi-year collaboration, announced in a June 17 news ...

Pittsburgh-based UPMC Enterprises, the venture capital arm of UPMC, led an $18.25 million Series B1 financing round for Carta Healthcare, a provider of AI-powered clinical data abstraction. Other ...

Icotrokinra demonstrated superior skin clearance at Weeks 16 and 24 compared to deucravacitinib and similar adverse event rates to placebo in Phase 3 ICONIC-ADVANCE studies Icotrokinra also showed ...

AI-enabled clinical data abstraction company Carta Healthcare has scored $18.25 million in Series B1 financing led by UPMC Enterprises. New investors MemorialCare Innovation Fund, Tampa General ...

The central promise of precision medicine is to provide right-sized and personalized care, patient by patient, instead of hewing to a singular clinical pathway for all patients who have a particular ...

Preliminary data from ongoing Phase 1/2 trial show dose dependent target engagement and provide clinical proof-of-mechanism for GRWD5769, demonstrating ability to modulate the human immunopeptidome ...

NEWTON, Mass.--(BUSINESS WIRE)--Inflammasome Therapeutics (https://www.inflam.com/), a clinical-stage biotech company developing novel, first-in-class dual ...